tyrosyl-arginyl-phenylalanyl-lysinamide has been researched along with paynantheine in 1 studies
| Studies (tyrosyl-arginyl-phenylalanyl-lysinamide) | Trials (tyrosyl-arginyl-phenylalanyl-lysinamide) | Recent Studies (post-2010) (tyrosyl-arginyl-phenylalanyl-lysinamide) | Studies (paynantheine) | Trials (paynantheine) | Recent Studies (post-2010) (paynantheine) |
|---|---|---|---|---|---|
| 74 | 0 | 17 | 8 | 0 | 7 |
| Protein | Taxonomy | tyrosyl-arginyl-phenylalanyl-lysinamide (IC50) | paynantheine (IC50) |
|---|---|---|---|
| Mu-type opioid receptor | Homo sapiens (human) | 2.2 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imam, MZ; Kong, D; Kuo, A; Smith, MT; Williams, CM | 1 |
1 other study(ies) available for tyrosyl-arginyl-phenylalanyl-lysinamide and paynantheine
| Article | Year |
|---|---|
Analgesic Opioid Ligand Discovery Based on Nonmorphinan Scaffolds Derived from Natural Sources.
Topics: Analgesics, Opioid; Animals; Biological Products; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Discovery; Humans; Ligands; Pain; Peptides; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2022 |